June 17, 2008 - Depomed, Inc. (NASDAQ:DEPO) announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for U.S. patent application number 10/280,309.
Paul B. Simboli, Depomed's director of Intellectual Property, noted that the patent contains claims directed to methods for treating neuropathic pain and claims related to methods for delivering compounds via specific dosage form technologies.
The whole story can be read here.
No comments:
Post a Comment